This is unpublished

Drs. Ian de Boer, Michael Kelly, Matt Rivara, John Stivelman, Kleber Fertrin

December 19, 2025
Special In-person event at SLU-Brotman: 40th Anniversary of Erythropoietin use in Nephrology
Pinned

Special Session:
40th Anniversary of Erythropoietin Clinical Trials in Seattle

Drs. Ian de Boer, Michael Kelly, Matt Rivara, John Stivelman, and Kleber Fertrin

Part 1 Presentation:

Development of Erythropoietin: A Local History of Bedside-Bench-Bedside Innovation

Ian de Boer, MD

Ian de Boer, MD, MS
Professor of Medicine
Division of Nephrology

 

mike kelly

 

Michael Kelly, MD
Clinical Professor Emeritus
Division of Nephrology

Dialysis, Dollars, and Hemoglobin: The Evolution of ESA Therapy in ESKD in the United States

Matt Rivara, MD

Matt Rivara, MD
Associate Professor of Medicine
Division of Nephrology

 

john stivelman

 

John Stivelman, MD
Professor Emeritus
Division of Nephrology

 

Part 2 Presentation:

Beyond EPO and Iron: Tricking The Oxygen Sensor In CKD Anemia

Kleber Fertrin, MD

 

Kleber Yotsumoto Fertrin, MD, PhD
Associate Professor of Medicine
Division of Hematology and Oncology

 

 

Matt Rivara, MD
Matthew Rivara MD
Associate Professor, Division of Nephrology
University of Washington
Chief Medical Officer, Northwest Kidney Centers
Ian de Boer, MD
Ian de Boer, MD, MS
Professor, Division of Nephrology
University of Washington
Joseph W. Eschbach Endowed Chair in Kidney Research
Director of Research, Nephrology
Director, Kidney Research Institute
Kleber Fertrin, MD
Kleber Yotsumoto Fertrin, MD, PhD
Associate Professor, Division of Hematology and Oncology
University of Washington School of Medicine
Director, Sickle Cell Disease and Iron Overload Program, Fred Hutch Cancer Center